BJL
HBIO icon

Brighton Jones LLC’s Harvard Bioscience HBIO Stock Holding History

Brighton Jones LLC’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,501
Closed -$11K – 426
2025
Q3 		$11K Sell
2,501
-8
-0.3% -$38 ﹤0.01% 1024
2025
Q2 		$11.1K Buy
2,509
+9
+0.4% +$38 ﹤0.01% 925
2025
Q1 		$14.2K Hold
2,500
– – ﹤0.01% 698
2024
Q4 		$52.8K Sell
2,500
-37
-1% -$850 ﹤0.01% 668
2024
Q3 		$68.2K Buy
+2,537
New +$74.7K ﹤0.01% 565

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM

Brighton Jones LLC's HBIO Position: Q4 2025 in Review

Brighton Jones LLC sold out of Harvard Bioscience (HBIO) in Q4 2025, closing a stake of 2,501 shares — an estimated $11K sold.

Brighton Jones LLC first reported a position in HBIO in Q3 2024 and held it in 5 quarters. The position peaked at $68.2K in Q3 2024. 64 funds tracked by Wall St. Rank hold HBIO as of Q4 2025.

  • Brighton Jones LLC reported no remaining Harvard Bioscience position as of Q4 2025 after selling out during the quarter.
  • Brighton Jones LLC sold 2,501 Harvard Bioscience shares in Q4 2025, an estimated $11K.
  • Brighton Jones LLC first reported a position in Harvard Bioscience in Q3 2024 and held it in 5 quarters.
  • Brighton Jones LLC's Harvard Bioscience position peaked at $68.2K in Q3 2024.
  • 64 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2025.

Based on Brighton Jones LLC's 13F filing for Q4 2025, filed 27 Jan 2026.